Results
1
1 companies
argenx
Market Cap: €29.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€480.50
7D
3.1%
1Y
12.7%